title: African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer.
abstract: BACKGROUND
  African American women more often present with more aggressive types of breast cancer than Caucasian women, but little is known whether genetic polymorphisms specific to or disproportionate in African Americans are associated with their risk of breast cancer.
  
  
  METHODS
  A population-based case-control study was conducted including 194 cases identified through the Metropolitan Detroit Cancer Surveillance System and 189 controls recruited through random digit dialing to examine polymorphisms in genes involved in estrogen metabolism and action.
  
  
  RESULTS
  The African American-specific CYP1A1 5639C allele was associated with an increased risk of breast cancer (odds ratio (OR)=2.34, 95% confidence interval (CI) 1.23-4.44) and this association with the CYP1A1 5639 locus was dependent on another polymorphism in the CYP3A4 gene (P=0.043 for the interaction). In addition, African American-predominant CYP1B1 432 Val allele was significantly more often found in the cases than in the controls overall and the HSD17B1 312 Gly allele was specifically associated with premenopausal breast cancer risk (OR=3.00, 95%CI 1.29-6.99).
  
  
  CONCLUSIONS
  These observations need to be confirmed in larger studies due to the limited statistical power of the study based on a small number of cases.
authors.affiliation: Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA. katoi@karmanos.org
authors.forename: Ikuko
authors.initials: I
authors.lastname: Kato
authors.forename: Michelle
authors.initials: M
authors.lastname: Cichon
authors.forename: Cecilia L
authors.initials: CL
authors.lastname: Yee
authors.forename: Susan
authors.initials: S
authors.lastname: Land
authors.forename: Jeannette F
authors.initials: JF
authors.lastname: Korczak
mesh_terms: D000328:Adult; D001741:Black or African American / Q000235:genetics*; D000368:Aged; D000369:Aged, 80 and over; D001189:Aryl Hydrocarbon Hydroxylases; D001943:Breast Neoplasms / Q000453:epidemiology / Q000208:ethnology / Q000235:genetics*; D016022:Case-Control Studies; D019363:Cytochrome P-450 CYP1A1 / Q000235:genetics; D065633:Cytochrome P-450 CYP1B1; D051544:Cytochrome P-450 CYP3A / Q000235:genetics; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D004960:Estradiol Dehydrogenases / Q000235:genetics; D004967:Estrogens / Q000378:metabolism*; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D016015:Logistic Models; D008875:Middle Aged; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D017697:Premenopause; D012307:Risk Factors
chemical_list: D004967:Estrogens; D003577:Cytochrome P-450 Enzyme System; D004960:Estradiol Dehydrogenases; C513331:HSD17B1 protein, human; D001189:Aryl Hydrocarbon Hydroxylases; C585496:CYP1B1 protein, human; D019363:Cytochrome P-450 CYP1A1; D065633:Cytochrome P-450 CYP1B1; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human
references.citation: Cancer Res. 2006 Feb 15;66(4):2468-75
references.pmid: 16489054
references.citation: Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):517-22
references.pmid: 9232339
references.citation: Oncologist. 2005 Jan;10(1):1-14
references.pmid: 15632248
references.citation: Am J Epidemiol. 2007 Feb 1;165(3):235-45
references.pmid: 17110639
references.citation: Cancer Lett. 2005 Sep 28;227(2):115-24
references.pmid: 16112414
references.citation: Chem Res Toxicol. 1991 Jul-Aug;4(4):391-407
references.pmid: 1912325
references.citation: Cancer Res. 1997 Mar 15;57(6):1063-5
references.pmid: 9067272
references.citation: Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):3-28
references.pmid: 10667460
references.citation: Breast Cancer Res. 2004;6(4):R460-73
references.pmid: 15217514
references.citation: Cancer. 2004 Jul 15;101(2):353-62
references.pmid: 15241834
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1998-2003
references.pmid: 16103451
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):513-20
references.pmid: 12050091
references.citation: Endocrinology. 2003 Aug;144(8):3382-98
references.pmid: 12865317
references.citation: Am J Epidemiol. 2005 May 15;161(10):901-15
references.pmid: 15870154
references.citation: Cancer Res. 2001 Jan 15;61(2):785-9
references.pmid: 11212283
references.citation: Mol Aspects Med. 2006 Aug;27(4):299-402
references.pmid: 16914190
references.citation: J Natl Cancer Inst. 2005 Nov 16;97(22):1671-9
references.pmid: 16288120
references.citation: Pharmacogenetics. 2003 Oct;13(10):607-18
references.pmid: 14515059
references.citation: Am J Epidemiol. 2007 Jan 15;165(2):115-25
references.pmid: 17053044
references.citation: Pharmacogenetics. 2000 Jun;10(4):343-53
references.pmid: 10862525
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):444-50
references.pmid: 17372239
references.citation: Pharmacogenomics. 2006 Sep;7(6):935-42
references.pmid: 16981851
references.citation: Int J Cancer. 2003 Apr 20;104(4):450-7
references.pmid: 12584742
references.citation: Pharmacol Ther. 1993 Feb-Mar;57(2-3):237-57
references.pmid: 8361994
references.citation: Clin Chem Lab Med. 2005;43(7):702-6
references.pmid: 16207128
references.citation: Cancer Res. 2007 Jan 15;67(2):812-7
references.pmid: 17234793
references.citation: Am J Epidemiol. 2004 Nov 1;160(9):825-41
references.pmid: 15496535
references.citation: Am J Hypertens. 2005 Nov;18(11):1388-95
references.pmid: 16280269
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1236-45
references.pmid: 17548691
references.citation: Am J Epidemiol. 2005 Jan 1;161(1):40-51
references.pmid: 15615914
references.citation: Am J Med. 2006 Sep;119(9 Suppl 1):S44-51
references.pmid: 16949388
references.citation: Cancer Res. 1998 Nov 15;58(22):5038-41
references.pmid: 9823305
references.citation: IARC Sci Publ. 1980;(32):5-338
references.pmid: 7216345
references.citation: Cancer Res. 2000 Jan 15;60(2):235-7
references.pmid: 10667565
references.citation: Cancer Res. 1998 Jan 1;58(1):65-70
references.pmid: 9426059
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):124-32
references.pmid: 16434597